Pacira Pharmaceuticals reported $667.02M in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acelrx Pharmaceuticals ACRX:US $ 42.81M 12.68M
Aerie Pharmaceuticals AERI:US $ 316.97M 38.68M
Amerisourcebergen ABC:US $ 39409.74M 30.86M
Astellas Pharma 4503:JP Y 923354M 15977M
Bristol Myers Squibb BMY:US $ 30121M 3141M
Cara Therapeutics CARA:US $ 151.76M 21.53M
Coherus Biosciences CHRS:US $ 512.44M 89.88M
Depomed DEPO:US $ 125.12M 21.62M
Endo International Ordinary Shares ENDP:US $ 2492.79M 221.79M
Heron Therapeutics HRTX:US $ 222.59M 31.83M
Horizon Pharma HZNP:US $ 2947.73M 147.96M
Ironwood Pharmaceuticals IRWD:US $ 710.1M 35.12M
JAZZ PHA JAZZ:US $ 2500.86M 110.48M
Lannett LCI:US $ 318.7M 15.91M
Ligand Pharmaceuticals LGND:US $ 276.07M 188.68M
Nektar Therapeutics NKTR:US $ 795.58M 190.55M
Omeros OMER:US $ 210.22M 37.67M
Pacira Pharmaceuticals PCRX:US $ 667.02M 199.03M
Perrigo Ordinary Shares PRGO:US $ 3935.5M 75.6M
Revance Therapeutics RVNC:US $ 285.33M 39.21M
Supernus Pharmaceuticals SUPN:US $ 568.52M 33.07M
Teva Pharmaceutical TEVA:IT 12.45B 122M
Xeris Pharmaceuticals Inc XERS:US $ 177.55M 34.95M
Xoma XOMA:US $ 89.61M 7.36M
Zoetis ZTS:US $ 6837M 93M